Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B)
- 21 October 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (45), 7313-7318
- https://doi.org/10.1016/j.vaccine.2010.08.076
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Efficient Serum Clearance of Botulinum Neurotoxin Achieved Using a Pool of Small Antitoxin Binding AgentsInfection and Immunity, 2010
- Antibody Protection against Botulinum Neurotoxin Intoxication in MiceInfection and Immunity, 2009
- Characterization of New Formalin-Detoxified Botulinum Neurotoxin ToxoidsClinical and Vaccine Immunology, 2008
- The Role of Systemic Handling in the Pathophysiologic Actions of Botulinum ToxinJournal of Pharmacology and Experimental Therapeutics, 2008
- Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal RouteInfection and Immunity, 2007
- Genetic Diversity among Botulinum Neurotoxin-Producing Clostridial StrainsJournal of Bacteriology, 2007
- An Initial Assessment of the Systemic Pharmacokinetics of Botulinum ToxinJournal of Pharmacology and Experimental Therapeutics, 2006
- Human Botulism Immune Globulin for the Treatment of Infant BotulismNew England Journal of Medicine, 2006
- BotulismClinical Infectious Diseases, 2005
- Deciphering antibody properties that lead to potent botulinum neurotoxin neutralizationMovement Disorders, 2004